<SEC-DOCUMENT>0001415889-23-007372-index.html : 20230504
<SEC-HEADER>0001415889-23-007372.hdr.sgml : 20230504
<ACCEPTANCE-DATETIME>20230504183356
ACCESSION NUMBER:		0001415889-23-007372
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230502
FILED AS OF DATE:		20230504
DATE AS OF CHANGE:		20230504

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Smaldone Alsup Laurie
		CENTRAL INDEX KEY:			0001589602

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36033
		FILM NUMBER:		23890571

	MAIL ADDRESS:	
		STREET 1:		190 WOOSAMONSA RD
		CITY:			PENNINGTON
		STATE:			NJ
		ZIP:			08534

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theravance Biopharma, Inc.
		CENTRAL INDEX KEY:			0001583107
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		UGLAND HOUSE, SOUTH CHURCH STREET
		CITY:			GEORGE TOWN, GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
		BUSINESS PHONE:		650-808-6000

	MAIL ADDRESS:	
		STREET 1:		UGLAND HOUSE, SOUTH CHURCH STREET
		CITY:			GEORGE TOWN, GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-05042023_100550.xml
<TEXT>
Document 1 - file: form4-05042023_100550.html

Document 1 - RAW XML: form4-05042023_100550.xml

</DOCUMENT>
</SEC-DOCUMENT>